## India's Unapproved Opioid Pipeline: 300+ Million Tapentadol Pills Flood West Africa
A vast, unregulated pipeline of synthetic opioids is flowing from India into West Africa, a region already struggling with an escalating drug abuse epidemic. An investigation by Bellingcat and Newslaundry reveals that Indian companies have shipped over 320 million pills of the potent painkiller tapentadol to West Africa in just three years, despite the drug not being approved for use in most destination countries. The shipments, comprising more than 1,400 consignments valued at nearly $130 million, represent a systematic flooding of the market with a substance two to three times more potent than tramadol.

The trade data, sourced from provider 52wmb, details a relentless export operation from January 2023 through December 2025. Dozens of Indian pharmaceutical suppliers are implicated in sending these massive consignments to West African nations. Where dosage information was available, the data indicates the shipments contained more than 300 million individual pills, creating a staggering inventory of unapproved and highly addictive medication.

This unapproved pharmaceutical trade directly undermines public health efforts in West Africa and raises serious questions about regulatory oversight in both the exporting and importing regions. The scale of the shipments suggests a well-established supply chain exploiting regulatory gaps, potentially fueling the very opioid crisis that local governments are attempting to combat. The findings prompt scrutiny of international pharmaceutical trade controls and the due diligence practices of companies involved in this high-volume, high-risk export market.
---
- **Source**: Bellingcat
- **Sector**: The Vault
- **Tags**: pharmaceutical_trade, opioid_crisis, West_Africa, regulatory_failure, supply_chain
- **Credibility**: unverified
- **Published**: 2026-04-17 14:22:46
- **ID**: 69635
- **URL**: https://whisperx.ai/en/intel/69635